Renal injury has a strong relationship to the subsequent development of renal fibrosis. In developing renal fibrosis, tubular epithelial cells in the kidney underwent epithelial–mesenchymal transition (EMT). Matrix metalloproteinase 7 (MMP7) was reported to reduce E-cadherin and induce EMT by up-regulation of β-catenin/lymphoid enhancer-binding factor 1 (LEF1) signaling. In this research, we tried to evaluate the role of resveratrol (RSV) on EMT process in renal injury and fibrosis. Human tubular epithelial cell HK-2 cells were treated with aristolochic acid (AAs) and transforming growth factor-β(TGF-β) to induce EMT with or without the administration of RSV. The inhibitory role of RSV on EMT in renal injury and fibrosis was determined by Western blotting, real-time PCR, and immunofluorescence staining. The EMT repressing role of RSV was also evaluated in vivo by renal ischemia-reperfusion (I/R) injury and unilateral ureteral obstruction (UUO) models. The underlying mechanism was investigated by shRNA interfering MMP7 and sirtuin 1 (SIRT1) expression. The results indicated that RSV reversed human kidney 2 (HK-2) cell EMT, renal I/R injury, and renal fibrosis. MMP7 inhibition was responsible for RSV-induced EMT repression. SIRT1 was up-regulated by RSV inhibited TGF-β pathway on MMP7 via deacetylating Smad4. In conclusion, RSV attenuated renal injury and fibrosis by inhibiting EMT process which was attributed to the fact that the up-regulated SIRT1 by RSV deacetylated Smad4 and inhibited MMP7 expression.
WuSTSunGHHsuCYHuangCSWuYHWangHHSunKH. Tumor necrosis factor-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism. Exp Biol Med2011; 236: 1022–9.
2.
RosasIORichardsTJKonishiKZhangYGibsonKLokshinAELindellKOCisnerosJMacdonaldSDPardoA. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med2008; 5: 0050093.
3.
LiQParkPWWilsonCLParksWC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell2002; 11: 635–46.
4.
McGuireJKLiQParksWC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol2003; 162: 1831–43.
5.
LiuCFengPLiXSongJChenW. Expression of MMP-2, MT1-MMP, and TMP-2 by cultured rabbit corneal fibroblasts under mechanical stretch. Exp Biol Med2014; 239: 907–12.
6.
ChenGBridenbaughEAAkintolaADCataniaJMVaidyaVSBonventreJVDearmanACSampsonHWZawiejaDCBurghardtRC. Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction. Am J Physiol Renal Physiol2007; 293: 1.
7.
ShibataSIMarushimaHAsakuraTMatsuuraTEdaHAokiKMatsudairaHUedaKOhkawaK. Three-dimensional culture using a radial flow bioireactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGF beta 1/Smad pathway. Int J Oncol2009; 34: 1433–48.
8.
FremontL. Biological effects of resveratrol. Life Sci2000; 66: 663–73.
9.
AggarwalBBBhardwajAAggarwalRSSeeramNPShishodiaSTakadaY. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res2004; 24: 2783–840.
10.
WallerathTDeckertGTernesTAndersonHLiHWitteKForstermannU. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation2002; 106: 1652–8.
11.
de Jesus SoaresTVolpiniRAFrancescatoHDCostaRSda SilvaCGCoimbraTM. Effects of resveratrol on glycerol-induced renal injury. Life Sci2007; 81: 647–56.
12.
KolgaziMSenerGCetinelSGedikNAlicanI. Resveratrol reduces renal and lung injury caused by sepsis in rats. J Surg Res2006; 134: 315–21.
13.
JungYJLeeJELeeASKangKPLeeSParkSKLeeSYHanMKKimDHKimW. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-kappaB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun2012; 419: 206–10.
14.
ChanderVChopraK. Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg2005; 42: 1198–205.
15.
LiangJTianSHanJXiongP. Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction. Ren Fail2014; 36: 285–91.
16.
LiJChongTWangZChenHLiHCaoJZhangPLiH. A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells. Mol Med Rep2014; 10: 1717–24.
17.
BaribeauSChaudhryPParentSAsselinE. Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines. Plos One2014; 9: e86987.
18.
TsaiJHHsuLSLinCLHongHMPanMHWayT-DChenWJ. 3,5,4′-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/beta-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Toxicol Appl Pharmacol2013; 272: 746–56.
19.
LiWMaJMaQLiBHanLLiuJXuQDuanWYuSWangF. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-kappa B pathway. Curr Med Chem2013; 20: 4185–94.
20.
BaiYHLuHWuCZLiangYWangSLLinCCChenBCXiaP. Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway. Biochem Pharmacol2014; 92: 484–93.
21.
SimicPWilliamsEOBellELGongJJBonkowskiMGuarenteL. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. Cell Rep2013; 3: 1175–86.
22.
HowitzKTBittermanKJCohenHYLammingDWLavuSWoodJGZipkinREChungPKisielewskiAZhangLL. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature2003; 425: 191–6.
23.
KitadaMKoyaD. Renal protective effects of resveratrol. Oxid Med Cell Longev2013; 2013: 568093.
24.
WangHZhangHTangLChenHWuCZhaoMYangYChenXLiuG. Resveratrol inhibits TGF-beta 1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology2013; 303: 139–46.
25.
GuarenteL. Sirtuins, aging, and medicine. New Eng J Med2011; 364: 2235–44.
26.
HeWWangYZhangMZYouLDavisLSFanHYangHCFogoABZentRHarrisRC. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest2010; 120: 1056–68.
27.
LiuY. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol2004; 15: 1–12.
28.
IwanoMPliethDDanoffTMXueCOkadaHNeilsonEG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest2002; 110: 341–50.
29.
ZavadilJBottingerEP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene2005; 24: 5764–74.
30.
BoutetADe FrutosCAMaxwellPHMayolMJRomeroJNietoMA. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. Embo J2006; 25: 5603–13.
31.
ThieryJPAcloqueHHuangRYJAngela NietoM. Epithelial-mesenchymal transitions in development and disease. Cell2009; 139: 871–90.
32.
KitamuraTBiyajimaKAokiMOshimaMTaketoMM. Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas. Lab Invest2009; 89: 98–105.
33.
ChenICChiangWFHuangHHChenPFShenYYChiangHC. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer2014; 13: 254.
34.
SimicPWilliamsEOBellELGongJJBonkowskiMGuarenteL. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. Cell Rep2013; 3: 1175–86.
